Lantern Pharma Inc. (LTRN) PT Raised to $36 at H.C. Wainwright

March 11, 2022 6:23 AM EST
Get Alerts LTRN Hot Sheet
Price: $5.62 -1.58%

Rating Summary:
    2 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
H.C. Wainwright analyst Michael King raised the price target on Lantern Pharma Inc. (NASDAQ: LTRN) to $36.00 (from $34.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change